Exhibit 99.1 QIAGEN N.V. and Subsidiaries U.S. GAAP Quarterly Report for the Period Ended March 31, 2024 Table of Contents Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets as of March 31, 2024 (unaudited) and December 31, 2 2023 Condensed Consolidated Statements of Income (unaudited) for the three months ended 4 March 31, 2024 and 2023 Condensed Consolidated Statements of Comprehensive Income (unaudited) for the three months 5 ended March 31, 2024 and 2023 Condensed Consolid ...

| --- | --- | --- | |--------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Q1 2024 results | | | | On track to achieve 2024 goals | | | | April 29, 2024 | | | Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. ...

Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Conference Call April 30, 2024 9:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & IR Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Matthew Sykes - Goldman Sachs Aisyah Noor - Morgan Stanley Michael Ryskin - Bank of America Hugo Solvet - BNP Paribas Patrick Donnelly - Citi Jack Meehan - Nephron Research Catherine Schulte - Baird Falko Friedrichs - Deutsche Bank Daniel Leonard ...

QIAGEN N.V.’s (QGEN) first-quarter 2024 adjusted earnings per share (EPS) were 46 cents and 47 cents at constant exchange rate (CER), down 9.8% year over year. However, the figure topped the Zacks Consensus Estimate by 4.6%.The adjustment excludes the impact of certain non-recurring items like business integration, acquisition and restructuring-related expenses, purchased intangible amortization expenses and non-cash interest expense charges, among others.The GAAP EPS for the quarter was 36 cents, down 2.7% ...

For the quarter ended March 2024, Qiagen (QGEN) reported revenue of $458.8 million, down 5.5% over the same period last year. EPS came in at $0.46, compared to $0.53 in the year-ago quarter.The reported revenue represents a surprise of +0.73% over the Zacks Consensus Estimate of $455.5 million. With the consensus EPS estimate being $0.44, the EPS surprise was +4.55%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expecta ...

Qiagen (QGEN) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.53 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.55%. A quarter ago, it was expected that this diagnostic products maker would post earnings of $0.56 per share when it actually produced earnings of $0.55, delivering a surprise of -1.79%.Over the last four quarters, the ...

预测财报 - 预计Qiagen (QGEN)将在即将发布的财报中每股盈利为0.44美元，同比下降17%[1] - 预计收入将达到454.97亿美元，较去年同期下降6.3%[1] 分析师预期 - 在过去30天内，对本季度的共识每股收益预期没有进行修订，这表明分析师在此期间内对其最初预测进行了集体重新考虑[2] - 投资者通常依赖于共识盈利和收入预期来评估本季度的业绩，但深入分析分析师对某些关键指标的预测往往能提供更全面的理解[4] 财报前考虑 - 在公司发布财报之前，重要的是要考虑到对盈利预测所做的任何修订，这些修订是预测投资者对股票可能行为的关键标尺[3]

Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE:QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024. Press release date / time: Monday, April 29, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Tuesday, April 30, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.  Three options for joining the conference call Register for call back connection - Click here: C ...

Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024. Press release date / time: Monday, April 29, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Tuesday, April 30, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.  Three options for joining the conference call Register for call back connection - Click here: ...

QIAGEN N.V. (QGEN) recently announced a sequence of new products to augment cancer research further and to enable urine collection and stabilization as a new approach for liquid biopsy. The three new products, coupled with the IVD version of QIAGEN's digital PCR platform QIAcuity, are planned to be released in mid-2024.The new products are likely to be featured at the annual meeting of the American Association for Cancer Research (AACR) in San Diego, California, from Apr 5-10.Product DetailsThe first produc ...